Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Adaptive Biotechnologies (ADPT US)
Watchlist
5
Analysis
Health Care
•
United States
Adaptive Biotechnologies Corporation provides life science equipment. The Company offers testing instruments for diagnose, treat, and monitor disease. Adaptive Biotechnologies serves customers in the United States.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Rigetti Computing
•
26 Nov 2025 06:06
Back to Near-Term Bullish on SPX and Nasdaq 100; Supports Held at SPX 6480-6520 and QQQ $580-583
Back to Near-Term Bullish on $SPX and Nasdaq 100 $NDX; Crucial Supports Held at 6480-6520 on SPX and $580-$583 on $QQQ, we are near-term bullish as...
Vermilion Research
Follow
377 Views
Share
bullish
•
Circle Internet Group
•
08 Oct 2025 05:53
Downgrading Financials to Underweight; Growth Themes Galore; Health Care Breaking Out
Downgrading Financials $XLF to Underweight; Growth Themes Galore: quantum, nuclear, hydrogen, space, robotics, drones, data centers, solar,...
Vermilion Research
Follow
639 Views
Share
bearish
•
S&P 500 INDEX
•
20 May 2020 07:34
U.S. Equity Strategy: Round Trip Back To Resistance
Our base case continues to be for near-term consolidation while the market determines the implications of states’ reopening (i.e., the...
Vermilion Research
Follow
430 Views
Share
bearish
•
S&P 500 INDEX
•
31 Mar 2020 21:34
U.S. Equities: Test Of The Lows Coming?
Now that the initial/primary low has been established and with the S&P 500 roughly 20% off the lows, we believe it is time to map out potential...
Vermilion Research
Follow
535 Views
Share
bullish
•
Adaptive Biotechnologies
•
24 Jun 2019 08:30
Adaptive Biotechnologies IPO: Immune to Grow and Succeed; and the Future Looks Good
Adaptive Biotechnologies (ADPT US)Â has filed for an IPO in the US to raise approximately US$181m and has set an IPO price range of US$15-17 per...
Shifara Samsudeen, FCMA, CGMA
Follow
472 Views
Share
1
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x